# Kyverna Therapeutics, Inc.: Form 8-K, filed Dec 15, 2025

- Company: [Kyverna Therapeutics, Inc.](/companies/kytx.md) (CIK 1994702)
- Form: 8-K
- Filed: 2025-12-15
- Accepted by EDGAR: Dec 15, 2025, 08:00 ET
- Period: 2025-12-15
- Accession: 0001193125-25-318469
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1994702/000119312525318469/d33692d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1994702/000119312525318469/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1994702/000119312525318469/d33692d8k.htm

Filed Dec 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-318469. Last ingested by Listed: Nov 12, 2026, 18:10 ET. No prices; not investment advice.
